date:Jan 15, 2019
or Fortetropin (No. 8,815,320) is entitled, Process for Producing a Composition Containing Active Follistatin. The patent details controlling the amount and concentration of avian follistatin in the composition.
To complicate matters further, there is no consensus on myostatin inhibitors among sports governing bodies. Some leagues mention myostatin inhibitors as prohibited, while others either dont mention the category specifically or are not clear about where myostatin inhibitors, including fo